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Available online 21 February 2008Dynorphins, endogeneous opioid peptides, function as ligands to the opioid kappa receptors but also induce
non-opioid excitotoxic effects. Dynorphin A can increase the intra-neuronal calcium concentration through a
non-opioid and non-NMDA mechanism. In this investigation, we show that big dynorphin, dynorphin A and
to some extent dynorphin A (1–13), but not dynorphin B, allow calcium to enter into large unilamellar
phospholipid vesicles with partly negative headgroups. The effects parallel the previously studied potency of
dynorphins to translocate through biological membranes and to cause calcein leakage from large unilamellar
phospholipid vesicles. There is no calcium ion inﬂux into vesicles with zwitterionic headgroups. We have also
investigated if the dynorphins can translocate through the vesicle membranes and estimated the relative
strength of interaction of the peptides with the vesicles by ﬂuorescence resonance energy transfer. The results
show that dynorphins do not translocate in this membrane model system. There is a strong electrostatic
contribution to the interaction of the peptides with the membrane model system.
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Energy transferDynorphins are endogenous opioid peptides widely distributed in
the central nervous system. They are synthesized in the striatum,
amygdala, hippocampus and other brain structures and also in the
spinal cord [1–8]. Dynorphins are all derivatives of prodynorphin [9].
The derivatives of prodynorphin are big dynorphin (Big Dyn),
dynorphin A (Dyn A) and dynorphin B (Dyn B). Consistent with their
anatomical localization, these peptides play a role in modulation of
reward induced by intake of addictive substances,motor control, stress
response, memory acquisition and pain processing [10–13]. Besides
opioid receptor interactions, dynorphins have a non-opioid physiolo-
gical activity. The non-opioid excitotoxic effects of the synthetic and
endogenous Dyn A and Big Dyn can result in neurodegeneration,
neuronal death and are relevant for pathophysiological processes
such as chronic neuropatic pain and spinal cord and brain injury
[14–20]. Non-opioid dynorphin actions can be blocked by antagonists
of the N-methyl-D-aspartate (NMDA) or alpha-amino-3-hydroxy-5-
methylisoxazole-4-propionate/kainate (AMPA) glutamate receptors
[9,13–15,18–21]. Cell imaging experiments have demonstrated that Dyn A8 155597.
Dyn, big dynorphin; Dyn A,
B, Dynorphin B; LUVs, large
2-oleoyl-phosphatidylcholine;
l-DHPE, N-(5-dimethylamino-
ero-3-phosphoethanolamine
tic acid; EGTA, ethylene glycol
RET, ﬂuorescence resonance
l rights reserved.can induce a time- and dose-dependent increase in intra-neuronal calcium
concentration through a non-opioid and non-NMDAmechanism [22].
Dynorphins share common properties with cell penetrating peptides
(CPP) [23]: the high content of hydrophobic and basic amino acid residues
and the ability to translocate across the cell plasma membrane without a
chiral receptor. All dynorphins interact with phospholipid unilamellar
vesicles with weak membrane-induced secondary structure in the
peptides [23]. Some non-opioid activities may be related to this property
of dynorphins. Big Dyn and Dyn A, but not Dyn B, were found to induce
leakage of calcein from largephospholipid unilamellar vesicleswithpartly
negative headgroups [24], indicating that they induce formation of
transient pores or other perturbations of the phospholipid bilayer.
Earlier reports on cell culture studies have suggested that certain
toxic agents may cause general permeability increases of the cell
membrane. Examples are the discodermin A peptide from the sea
sponge [25], as well soluble amyloid oligomers of various origins
[26], which have been reported to cause cell membrane permeability
to calcium as well as to ﬂuorescent dyes. So far however there have
been no such reports concerning native neuropeptides, potentially
involved in calcium signalling. This inspired us to investigate whether
the perturbations of the phospholipid bilayer by dynorphins would
also allow calcium to enter into phospholipid vesicles, by using a
calcium indicator entrapped in the large phospholipid unilamellar
vesicles (LUVs). We have also applied a ﬂuorescence resonance energy
transfer (FRET) methodology to investigate if dynorphin peptides can
translocate themembrane in the vesiclemodel system and to estimate
the electrostatic contributions and relative strength of interaction of
the peptides with the vesicle membranes.
Fig. 1. Time course of the change caused by Dyn A or Big Dyn in F340/F380 of fura-2
ﬂuorescence entrapped in POPC/POPG (70/30) or POPC (100) LUVs at 25 °C. The vesicles
(total phospholipid concentration 50 μM) contained 100 μM fura-2 and 200 μm EGTA. The
calcium concentrationwas 0.5mMoutside the vesicles.: (A) POPC/POPG (70/30) LUVs; (—)
no peptide; (— —) 0.25 μM Dyn A; (- - -) 0.55 μM Dyn A; (— -) 1 μM Dyn A; (— - -) 20 nM
Calcimycine. (B) POPC/POPG (70/30) LUVs; (—) no peptide; (— —) 0.3 μM Big Dyn; (- - -)
0.5 μM Big Dyn; (— -) 20 nM Calcimycine. LUVs: (C) POPC (100); (—) no peptide; (— —)
1.75 μM Dyn A; (- - -) 1.75 μM Big Dyn.
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1.1. Materials
Dyn A, dynorphin A (1–13) (Dyn A (1–13)), Big Dyn, Dyn B and penetratin (Table 1)
were produced by Neosystem Laboratoire, Strasbourg. The peptides studied herewere not
modiﬁed in the N- and C-termini. The purity of all peptides was N95%. 1-Palmitoyl-2-
oleoyl-phosphatidylcholine (POPC), 1-palmitoyl-2-oleoyl-phosphatidyl-glycerol (POPG)
were purchased from Avanti Polar Lipids, Alabaster, of the best quality, and used without
further puriﬁcation. Fura-2 and dansyl-DHPE were purchased from Molecular Probes.
1.2. Determination of peptide concentrations
The concentration of peptides in aqueous stock solutions was determined
spectrophotometrically at λ=280 nm on a CARY 4 spectrophotometer. A molar
absorptivity at 280 nm of 5690 M−1 cm−1 for one Trp and 1280 M−1 cm−1 for one Tyr
residue was applied in the calculations [27].
1.3. Preparation of large unilamellar vesicles
Largeunilamellar vesicles (LUVs)werepreparedby initiallydissolving thephospholipids
at the desired concentration (with the chosen POPG/POPC molar ratio) in a chloroform/
ethanol mixture, to ensure the complete mixing of the components, and then removing the
solvent by placing the sample in a high vacuum until the lipids were completely dried (2 h).
Thedried lipidsweredispersed in abuffer solution at pH7.4. Thedispersionwas run through
a freeze–thaw cycle ﬁve times and then passed through two polycarbonate ﬁlters (0.1 μm
pore size) 20 times in an Avanti manual extruder. The size of the vesicles was veriﬁed by a
light scattering analyzer (Zetasizer Nano ZS, Malvern Instruments, Malvern, UK).
1.4. Calcium Inﬂux Measurements
LUVswithentrapped fura-2werepreparedbyhydratinga lipidﬁlmofPOPC/POPG(70/30
molar ratio) or (100/0 molar ratio) composition. The dried lipids were dispersed in a buffer
solution containing 50mMKCl,10mMHEPES, 200 μMEGTA, and100 μMfura-2 at pH7.4. The
dispersion was run through a freeze–thaw cycle ﬁve times and then passed through two
polycarbonate ﬁlters (0.1 μm pore size) 20 times in an Avanti manual extruder. Fura-2 not
entrappedwasseparated fromtheLUVsbyﬁltrating twiceonSephadexG-25columns (PD-10,
Pharmacia Fine Chemicals). LUVs were used within 24 h after the gel ﬁltration. Phospholipid
concentrationwas determined as inorganic phosphate by the method of Bartlett.
Fura-2 ﬂuorescence was measured on a Horiba Jobin Yvon Fluorolog-3 spectro-
meter using the DataMax operating software. The rate of calcium inﬂux was monitored
by measuring the ratio of ﬂuorescence emission of fura-2 at 510 nm using the two
excitation wavelengths 340 and 380 nm, F340/F380, as a function of time. In a typical
assay, 50 μM of fura-2 entrapped LUVs was added to the fura-2 free buffer placed in a
10 mm quartz cuvette at 25 °C. Calcium inﬂux was initiated by adding 500 μM of
calcium; the peptides were added before calcium.
Thecalciumconcentration inside thevesicles, [Ca2+]iwascalculatedby theequation [28]:
Ca2þ
 
i ¼ Kd
R Rmin
Rmax  R
 
Sf2
Sb2
 
ð1Þ
where R is F340/F380, Rmin is F340/F380 at zero and Rmax is F340/F380 at calcium saturation.
Sf2 was the ﬂuorescence intensity at excitationwavelength 380 nm for free dye; and Sb2 was
the ﬂuorescence intensity at calcium saturation. KD=250 nM, Rmin=0.78, Rmax=4.71 and Sf2/
Sb2=2.32 were used.
The apparent permeability coefﬁcient (Π) of perturbed LUVmembranes to Ca2+ was
calculated by applying the ﬁrst Fick's law:
dQ
dt
¼ P  AdDc ð2Þ
where dQ/dt is the ﬂux of Ca2+ in mol s−1 m−2, P is the permeability coefﬁcient, A is the
surface areaof thevesicle andΔc is the concentrationdifferenceacross theLUVmembrane.
1.5. Fluorescence resonance energy transfer (FRET)
Dansyl-LUVs labeling were prepared by hydrating the lipid ﬁlm composed of POPC,
POPG, and dansyl-DHPE phospholipids (70/20/10 or 90/0/10 molar ratios, respectively).
(1)
( )Table 1
Amino acid sequences with their charges at pH 7.0 and their mean hydrophobicities
calculated according to Kyte and Doolittle [40]
Peptide Sequence Charge at
pH 7.0
Hydrophobicity
Dyn A YGGFLRRIRPKLKWDNQ +4 −1.26
Dyn A1–13 YGGFLRRIRPKLK +5 −0.78
Dyn B YGGFLRRQFKVVT +3 −0.11
Big Dyn YGGFLRRIRPKLKWDNQKRYGGFLRRQFKVVT +9 −0.98
Penetratin RQI KIWFQNRRMK WKK +7 −1.73
The sequences have non-modiﬁed N- and C-termini.The dried lipidswere dispersed in a buffer solution containing 50mMphosphate buffer at
pH 7.4. The dispersion was run through a freeze–thaw cycle ﬁve times and then passed
through twopolycarbonateﬁlters (0.1 μmpore size) 20 times in anAvantimanual extruder.
The observation of the ﬂuorescence intensity of the Trp residue (347 nm) upon excitation
at 280 nm allows us to monitor FRET from the Trp residue of the peptide to the dansyl
ﬂuorophore. Temperaturewas controlled at 25 °C. Fluorescencewasmeasured on aHoriba
Jobin Yvon Fluorolog-3 spectrometer using the DataMax operating software.
2. Results
2.1. Calcium inﬂux measurements
The effects of the peptides on the calcium permeability of a bio-
membrane model system were investigated by experiments using
phospholipid LUVswith entrapped fura-2 (100 μM), and observing the
ﬂuorescence intensity ratio F340/F380 which reﬂects the fraction of
Fig. 2. Time course of the change caused by peptides in F340/F380 of fura-2 ﬂuorescence
entrapped in POPC/POPG (70/30) LUVs at 37 °C. The vesicles (total phospholipid
concentration50μM)contained100μMfura-2 and200 μmEGTA.The calciumconcentration
was 0.5 mMoutside the vesicles. (A) (—) No peptide; (——) 1 μMDyn B. (B) (—) No peptide;
(——) 1 μMDynA (1-13); (- - -) 2 μMDynA (1-13). (C) (—)Nopeptide; (——) 1 μMpenetratin.
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were ﬁrst performed using phospholipid LUVs (50 μM) with partially
negatively charged headgroups, POPC/POPG (70/30 molar ratio) to
mimic the partially negative charged plasmamembranes of eukaryotic
cells, at 25 °C. Control experiments were performed to evaluate the
effects of membrane headgroup charge using vesicles with 100%
zwitterionic headgroups, POPC.
In the absence of peptides the addition of calcium to LUVs com-
posed of POPG/POPC (30/70) gives rise to an instant increase of the
ratio F340/F380 due to small amounts of fura-2which is bound outside
the LUVs, due to incomplete puriﬁcation (Fig. 1A). After the initial step
in ﬂuorescence ratio, the ratio F340/F380 remains stable, indicating
that calcium cannot pass through the membrane of the vesicles on the
investigated timescale. Adding Dyn A (0.25–1 μM) to the phospholipid
membrane with partially negatively charged headgroups causes
increase of calcium permeability, shown as a time-dependent increase
in F340/F380. The permeability increase is dependent on the
concentration of Dyn A (Fig. 1A).
The addition of the ionophore calcimycin (20 nM) to the vesicles
gives a much higher F340/F380 increase compared to Dyn A. This
shows that the induced calcium permeability due to Dyn A is relatively
weak. The calcium concentration inside the vesicles, evaluated using
Eq. (1), after a 7 min incubation period was found to be between 34
and 110 nM, and approximately proportional to the Dyn A concentra-
tion (or the P/L ratio of the peptide and the phospholipids) (Table 2).
The calcium permeability of the LUVs in the presence of Big Dyn
(Fig. 1B) is higher than in the presence of Dyn A. The calcium concen-
tration inside the vesicles is higher (162 nM) with a smaller concen-
tration of Big Dyn (0.5 μM) (Table 2).
Fig. 1C shows the results for DynA and Big Dyn when zwitter-
ionic POPC vesicles were used. No signiﬁcant Ca2+ inﬂux could be
detected with either peptide despite comparatively high concentra-
tions, 1.75 μM.
DynB (1 μM)does not induce calciumpermeabilization to the vesicle
under the same conditions as Dyn A, using POPC/POPG (70/30) vesicles
(Fig. 2A). Similarly, DynA (1–13),whichhas the samenumberof residues
as Dyn B causes only a small increase of calcium permeability (Fig. 2B).
The well-known CPP penetratin was investigated in a control experi-
ment andwas found to give a veryminor increase in the F340/F380 ratio
(Fig. 2C). Applying the ﬁrst Fick's law to transport across the membrane
using Eq. (2), we were able to evaluate the apparent permeability
coefﬁcients of the perturbedmembranes to Ca2+ (Table 2.). The apparent
Ca2+ permeability coefﬁcients are close to linear functionsof the P/L ratio
used in the experiments (or the peptide concentrations).
In the present study of calcium inﬂux into phospholipid vesicles, the
control experiments are important, to verify that the results are not due to
fura-2 leakage out of the vesicles. As separate experiment we therefore
veriﬁed that if calcium was added to a medium with lysed vesicles no
longer entrapping fura-2, the addition of 4 mM EDTA changed theTable 2
The calcium concentration inside POPC/POPG (70/30) vesicles as function of peptide
concentration and the P/L ratio for dynorphin peptides and penetratin
Peptide Concentration μM P/L ratio [Ca]i nM Π/m s−1
Dyn A 0.25 0.005 34 3.6×10−12
0.55 0.011 60 6.8×10−12
1 0.02 110 1.4×10−11
Big Dyn 0.3 0.006 85 1.0×10−11
0.5 0.01 162 2.4×10−11
Dyn B 1 0.02 b4 b4.1×10−13
Dyn A 1–13 1 0.02 10 1.0×10−12
2 0.04 15 1.5×10−12
Penetratin 1 0.02 4 4.1×10−13
(incubation time 7min at 25 °C) together with the apparent permeability coefﬁcient (Π)
of perturbed LUV membranes to Ca2+.ﬂuorescence ratio F340/F380 to that of fura-2 alone (data not shown). As a
control experiment we added the same EDTA concentration at the end of
the experiments where the vesicles were incubated with peptide and
calcium. This had only a minor effect on the F340/F380 ratio, most likely
due to the small amounts of fura-2 remaining outside of the vesicles after
puriﬁcation. Onlywhenhigh peptide concentrationswere added (≥1 μM),
we found that fura-2 starts to leak from the vesicles (data not shown).
Dynamic Light Scattering experiments were performed to probe
the potential size changes that may have occurred with the vesicles
during the experiments. Fig. 3A shows that the POPC/POPG vesicles
(500 μM) have a mean diameter of 120 nm, virtually unchanged by
addition of 5 μMBig Dyn, themost potent of the dynorphin peptides to
cause permeabilisation. Only a very small broadening of the size
distribution was seen. We take this as evidence that the peptide-
induced calcium permeability is not due to fusion of the vesicles.
Fig. 3. Size distribution of LUVs. (A) The total phospholipid concentrationwas 500 μM in
10 mM HEPES buffer pH 7.4 and 50 mM KCl. The POPC/POPG (70/30) vesicles contained
100 μM fura-2 and 200 μm EGTA. The calcium concentration outside the vesicles was
0.5 mM. (—) No peptide; (- - -) 5 μMof Big Dyn. (B) The total phospholipid concentration
was 300 μM (LUVs POPC/POPG/dansyl-DHPE (70/20/10)) in 0.5 mM phosphate buffer
pH 7.4 (1 mM K+). (- - -) No peptide; (—) 1 μM Big Dyn.
Fig. 4. FRET study of potential peptide translocation. Themediumwas 50mMphosphate
buffer (pH 7.4), total potassium concentration 100 mM. Temperature 25 °C. The peptide
concentrationwas 1 μM, and the lipid concentrationswere 300 μM. The Trp ﬂuorescence
at 347 nm was measured (excited at 280 nm). Peptides were mixed with dansyl-LUVs
(POPC/POPG/dansyl-DHPE (70/20/10)), at time-point 60 s①. At time-point 360 s, a large
excess (ﬁnal lipid concentration 2 mM) of a second population of dansyl-free LUVs
(POPC/POPG (70/30)) was added ②. ③ shows the simultaneous addition of both
populations of vesicles. (A) 1 μMDyn A; (B) 1 μM Big Dyn; (C) 1 μM penetratin; (D) 1 μM
Big Dynwith LUVs without POPG (POPC/dansyl-DHPE (90/10) and POPC/POPG (100/0)).
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According to the protocol described by Matsuzaki [29–31], peptide
translocation throughavesiclemembrane canbedetected bymeasuring
the fraction of peptides in contact with the membrane outer leaﬂet of
the LUVs. The untranslocated peptides can be removed from the mem-
brane surface by adding a large excess of a secondpopulation of vesicles.
The FRET from the Trp residues of the peptide to a dansyl chromophore
incorporated into the membrane of the ﬁrst population of vesicles
allows the determination of the peptide fraction which cannot be
removed, i.e. which has translocated across the membrane.
Fig. 4 shows the results of experiments following this protocol for
DynA, Big Dyn andpenetratin,whichwasused as a control peptide [32].
Since they contain noTrp, Dyn A (1–13) and Dyn B could not be studied
by this protocol. Following a time-line as indicated in Fig. 4, dansyl-
labeled vesicles (300 μM)were added to apeptide solution (1 μM),which
led to a decrease in Trp ﬂuorescence. This indicates FRET due to peptide
binding to the membrane. In addition, interaction with the dansyl-
labeled vesicles caused a blue shift of themaximum intensity of the Trp
emission, for the three peptides compared to the values observed in the
buffer: DynA shifted its emissionmaximum from358nmto 350nm, Big
Dyn from 358 nm to 348 nm and penetratin from 358 nm to 346 nm
(data not shown). After incubation of the peptide with the dansyl-
labeled vesicles, a second population of dansyl-free LUVs was added in
large excess (2 mM) at a later time-point, resulting in a relief from FRET
and a rapid increase in ﬂuorescence intensity. In a control experiment,
bothpopulationsof vesicleswere added at the same time, resulting in an
increased Trp ﬂuorescence. When both curves reach the same level of
Trp ﬂuorescence at the end of the experiment, this is interpreted to
mean that no fraction of peptide has escaped redistribution, i.e. no
1271L. Hugonin et al. / Biochimica et Biophysica Acta 1778 (2008) 1267–1273fraction of peptide has translocated into the interior of the ﬁrst vesicle
population. This translocation assay in 50 mM phosphate buffer of Dyn
A, Big Dyn andpenetratin showed that nodifference inﬂuorescencewas
observed between the experiments and the controls at the end of the
time-line. Therefore we conclude that Dyn A, Big Dyn as well as
penetratin had remained on the outer leaﬂet of the ﬁrst population of
vesicles and did not translocate through the phospholipid bilayer of the
LUVs. However, the kinetics of the redistribution to the second
population of vesicles was different for the three peptides: most rapid
for Dyn A (Fig. 4A), intermediate for penetratin (Fig. 4C) and slow for Big
Dyn (Fig. 4B). In presence of LUVs with less fraction of charged
headgroups (dansyl-labeled LUVs composed of POPC/dansyl-DHPE
(90/10) and dansyl-free LUVs composed of POPC/POPG (90/10)), the
redistribution of Big Dyn between both types of vesicles was immediateFig. 5. FRET study of strength of interaction of the peptides with LUVs. The mediumwas
0.5 mM phosphate buffer (pH 7.4), with total potassium concentration 1 mM.
Temperature 25 °C. The peptide concentration was 1 μM, and the lipid concentrations
were 300 μM. The Trp ﬂuorescence at 347 nm was measured (excited at 280 nm).
Peptides were mixed with dansyl-LUVs (POPC/POPG/dansyl-DHPE (70/20/10)) at time-
point 60 s ①. At time-point 360 s, a large excess (ﬁnal concentration of 2 mM) of a
second population of dansyl-free LUVs (POPC/POPG (70/30)) was added②.③ shows the
simultaneous addition of both populations of vesicles.④ shows the addition of 50 mM
KCl added at a time-point 420 s. (A) 1 μM Dyn A; (B) 1 μM Big Dyn; (C) 1 μM penetratin.(Fig. 4D). For Dyn A which showed rapid redistribution already with
the more charged vesicles, the removal of charge did not make any
observable change on the present timescale of seconds (data not shown).
We then went on to qualitatively probe the electrostatic contribu-
tion and the strength of association of the peptides with the bilayer
using a variant of the original protocol (Fig. 5). While the K+ concen-
tration was kept at 100 mM inside the vesicles it was considerably
decreased outside, to 1 mM. The initial FRET effect by addition of the
vesicles was unchanged. When the second population of vesicles was
added after 350 s, the three peptides again showed different kinetics of
redistribution, with Dyn A being the most rapid, and Big Dyn and
penetratin almost too slow tomeasure on the present timescale.When
in other experiments the K+ concentration was increased to 50 mM
1 min after the addition of the second population of vesicles, the
kinetics of redistribution increased for all three peptides, but their
relative order was unchanged, with Dyn A most rapid, followed by
penetratin and Big Dyn most slow.
Dynamic Light Scattering experiments were performed to probe the
potential size changes that may have occurred with the vesicles during
the experiments with the low K+ concentration. Fig. 3B shows that the
300 μM POPC/POPG vesicles have a mean diameter of 120 nm, virtually
unchanged by addition of 1 μM Big Dyn. Only a small broadening of the
size distributionwas seen, indicating that the peptide in presence of low
[K+] does not induce fusion of the phospholipid vesicles.
3. Discussion
Our previous studies have established that Big Dyn and to a lesser
extent Dyn A, but not Dyn B, efﬁciently translocate through cell mem-
branes of neuronal and non-neuronal cells [23] and perturb phospholipid
vesicle membranes causing leakage of vesicle-entrapped calcein [24].
The major goal of the present study was to determine whether
dynorphin peptides can allow calcium to permeate a phospholipid
bilayer, by studying the effect in phospholipid vesicles (by transloca-
tion, pore formation or perturbations of the phospholipid bilayer).
We found that indeed Dyn A and Big Dyn produce an increase in
intravesicular calcium [Ca2+]i in phospholipid LUVs. Dyn A (1–13) had
only a very small effect and Dyn Bwas found to be inactive. The control
experiment where addition of EDTA in the external medium gave only
insigniﬁcant effects on the fura-2 ﬂuorescence showed that the great
majority of the fura-2 complexes were present within the phospho-
lipid vesicles and that fura-2 does not leak outside of the LUVs under
the condition of the experiments (peptide concentration ≤1 μM).
It should be pointed out that the concentrations of peptides and
calciumused in the present studyare reasonably close to physiologically
relevant conditions. The peptide concentrations are sub-μM and the
measured calcium inﬂux is also sub-μM. In studies of cell permeabiliza-
tion by dynorphins, peptide concentrations are in the sub-μMrange and
the calcium inﬂux into cells induced by a variety of stimuli results in
increases in intracellular calcium concentrations to the sub-μM levels
[33]. In the CNS, calcium enters neurons from the extracellular space
where it is present atmillimolar concentrations [34]. The comparison of
elevated calcium concentrations in LUVs and stimulated cells suggests
that the dynorphin effects on calcium permeability may be biologically
relevant. Although previous studies involving toxic agents [25,26] have
suggested that membrane perturbations can give rise to general
permeability increases for a variety of agents including Ca2+ in cells,
the present study indicates that neuropeptides may also have this
property as part of their natural functions.
In excitable cells, like neuronal and muscle cells, Ca2+ entry is
accomplished by the opening of voltage- and ligand-gated Ca2+-
permeable ion channels. In non-excitable cells like the cells of the
immune system, endothelial, epithelial or glial cells, a complex
mechanism called store-operated Ca2+ entry seems to be operating.
The key feature of this regulatory mechanism is a dynamic interplay
between endoplasmic reticulum,mitochondria andplasmamembrane
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of this mechanism [37]. Mitochondrial uptake of Ca2+ seems to be
regulated through the mitochondrial membrane potential [38,39] and
our experiments may suggest a model for studying the mechanism of
mitochondrial uptake of Ca2+ at the molecular level.
In our model system with partially negatively charged LUVs, the
higher calcium permeabilization potency of Big Dyn compared to Dyn
A may be due to a combination of its higher positive charge (+9) and
its large length (Table 1). Both charge and length seem to play a role
for these effects, since Dyn A (1–13) has weaker effect than Dyn A,
even though it has higher positive charge (+5) but shorter length
compared to Dyn A (+4). Dyn B has the least positive charge (+3)
among the peptides and was found to be inactive. Penetratin on the
other hand is hardly active despite a high charge (+7). Table 1 also
includes a hydrophobicity index, estimated according to [40]. All
dynorphins are somewhat more hydrophobic than penetratin, but
there seems to be no general correlation between vesicle leakage and
peptide hydrophobicity. We conclude that there is no simple relation
linking the calcium permeabilization potency directly to the sequence
properties for the investigated peptides. Instead there may be
structure and membrane interaction differences that determine the
potencies of the different peptides. The membrane headgroup charge
is another parameter that strongly affects the membrane permeability
properties induced by the peptides.
There was no signiﬁcant inﬂux of Ca2+ induced by any of the
dynorphins in zwitterionic vesicles under the conditions where Big
Dyn and Dyn A caused inﬂux with the negatively charged vesicles. In
contrast, previous studies have shown that calcein leakage from inside
zwitterionic vesicles occurs in a similar dynorphin peptide concentra-
tion range as with negatively charged vesicles, although overall higher
peptide concentrations were used in those studies [24].
Numerous studies demonstrated that mechanochemical signal
transduction originates at the cell membrane and suggest that plasma
membrane lipids play a major role in mediating mechanochemical
signal transduction through lipid–protein interactions [41–44]. Ac-
cording to the kinetic theory of reactions strongly coupled to the
thermal motion of solvent molecules, such as the protein–lipid inter-
actions in the plasma membrane, the reaction rate is inversely pro-
portional to the viscosity (η):
k~
1
g
eDH=RT
In the above equation, H is the activation energy, R is the universal
gas constant and T the absolute temperature. If we consider the
translocation of a calcium ion through the bilayer a “reaction” in the
above sense, then a decrease in membrane microviscosity as affected
by peptide interaction has the same effect on the reaction rate as
lowering the overall reaction barrier, in a fashion that is similar to the
effect of a catalyst.
Our experiments with dynorphins show that Dyn A and Big Dyn
interact with the lipid bilayer of LUVs and perturb the membrane
causing calcium to permeate the phospholipid bilayer of the vesicles. It
was shown recently thatDynAcan induce a time- anddose-dependent
increase in intra-neuronal calcium concentration through a non-
opioid and non-NMDA mechanism [22]. This effect was attributed to
the activation of the bradykinin receptors [45]. New evidence acquired
on epithelial cells has shown that the bradykinin B2 receptor can be
activated in a ligand-independent way by shear stress or increase in
the plasmamembraneﬂuidity [46]. Together, these results suggest that
dynorphin's interaction with the plasma membrane may indeed
activate the bradykinin signaling cascade, but not necessarily through
direct interaction of dynorphins with the bradykinin receptor.
The FRET experiments were performed to try to link the calcium
inﬂux results to the electrostatic contribution and strength of the
membrane binding of the peptides. However, while Dyn A seems to bethe weakest binder of the three investigated peptides, its calcium
permeabilization potency is higher than that of penetratin. The
relatively small wavelength shifts in the Trp emission maxima upon
vesicle interaction for the three peptides suggest localization close to
the membrane surface for all three. In addition the FRET experiments
demonstrate that the membrane binding has a strong electrostatic
component, as shown by the effects of the varying K+ concentrations
outside of the vesicles.
Despite the fact that the ﬁrst seven residues of Dyn A and Dyn B are
identical, their interactions with phospholipid membranes are quite
different. An NMR study showed that only weak secondary structure
was induced by their interaction with lipid bilayers. However, Dyn A
was found to insert its N-terminus into the bilayer of the membrane,
while Dyn B was found to more completely reside at the surface of the
bilayer [47]. Such positioning differences may be related to the
different results for these two peptides with the calcium inﬂux
measurements, e.g. if transient pores or ion channels are preferentially
formed by a peptidewhich has a segment inserted into themembrane.
This explanation is in general agreement with previous observations
on peptide translocation across the bilayer and induction of leakage of
calcein from LUVs, induced by Big Dyn, and Dyn A, but not Dyn B [24]
and also by penetratin [48]: Big Dynwas found to be almost an order of
magnitude more potent than Dyn A and penetratin, while Dyn B was
inactive also in these two respects. The neurological activities of DynA,
and more potently of Big Dyn, and inactivity of Dyn B, to induce
nociceptive responses in mice through a non-opioid mechanism may
be reﬂected in the different potencies of the three dynorphin peptides
to mediate Ca2+ inﬂux through neuronal membranes.
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